Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Phase 3    crawled date : 2022 - 03 - 16    save search

Eiger BioPharmaceuticals to Host Conference Call to Discuss Phase 3 TOGETHER Study Results of Peginterferon Lambda for COVID-19 on Thursday, March 17, 2022
Published: 2022-03-16 (Crawled : 22:00) - biospace.com/
EIGR | $1.725 -1.45% 140K twitter stocktwits trandingview |
Health Technology
| | O: 1.28% H: 3.62% C: 3.08%

covid-19 day als biopharma conference covid results phase 3
Biogen Announces Peer-Reviewed Publication of ADUHELM® Phase 3 EMERGE and ENGAGE Data in The Journal of Prevention of Alzheimer’s Disease
Published: 2022-03-16 (Crawled : 16:00) - globenewswire.com
BIIB | $193.18 -0.48% -0.48% 1.4M twitter stocktwits trandingview |
Health Technology
| | O: 1.96% H: 1.5% C: 1.28%

aduhelm alzheimer disease phase 3 merge alzheimer’s alzheimer's disease alzheimer's
Long-Term Phase 3 Data Show ADUHELM® Continues to Reduce Underlying Pathologies of Alzheimer’s Disease in Patients Treated for More Than Two Years
Published: 2022-03-16 (Crawled : 12:00) - globenewswire.com
BIIB | $193.18 -0.48% -0.48% 1.4M twitter stocktwits trandingview |
Health Technology
| | O: 1.96% H: 1.5% C: 1.28%

aduhelm alzheimer disease phase 3 alzheimer’s alzheimer's disease alzheimer's
Karyopharm Announces Upcoming Presentations of Phase 3 SIENDO Study of Selinexor in Patients with Advanced or Recurrent Endometrial Cancer
Published: 2022-03-16 (Crawled : 12:00) - biospace.com/
KPTI | $1.085 -3.98% -4.15% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.8% H: 8.69% C: 6.38%

trial presentation cancer phase 3
Apellis Announces Pegcetacoplan Showed Continuous and Clinically Meaningful Effects at Month 18 in Phase 3 DERBY and OAKS Studies for Geographic Atrophy (GA)
Published: 2022-03-16 (Crawled : 11:00) - globenewswire.com
APLS G | $48.69 2.2% 2.16% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: 2.3% H: 14.33% C: 10.42%

phase 3
Gainers vs Losers
78% 22%

Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M twitter stocktwits trandingview |

AGBA | $2.94 135.2% 57.48% 66M twitter stocktwits trandingview |
Finance

EDBL | News | $6.46 71.81% 41.8% 2M twitter stocktwits trandingview |

MTC | $2.25 44.23% 30.67% 6M twitter stocktwits trandingview |
Technology Services

OPRT | News | $3.175 41.11% 29.13% 12M twitter stocktwits trandingview |
Finance

SHIM | $3.05 35.56% 26.23% 1.1M twitter stocktwits trandingview |

HKIT | $1.345 31.86% 24.16% 390K twitter stocktwits trandingview |
Technology Services

ABVC | $1.36 30.77% 23.53% 7.4M twitter stocktwits trandingview |
Wholesale Trade

OST | $0.512 28.0% 21.88% 290K twitter stocktwits trandingview |

POET | $1.59 27.2% 21.38% 4.2M twitter stocktwits trandingview |
Manufacturing


Your saved searches
Save your searches and get alerts when important news are released.